David Bain
Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Progesterone | 17 | 2014 | 343 | 3.140 |
Why?
| Thermodynamics | 19 | 2023 | 408 | 2.920 |
Why?
| Promoter Regions, Genetic | 14 | 2015 | 1207 | 2.420 |
Why?
| Receptors, Glucocorticoid | 6 | 2018 | 147 | 2.040 |
Why?
| DNA | 10 | 2015 | 1400 | 1.750 |
Why?
| Receptors, Steroid | 5 | 2015 | 49 | 1.460 |
Why?
| Response Elements | 9 | 2018 | 90 | 1.450 |
Why?
| Antibodies, Monoclonal | 3 | 2023 | 1367 | 1.310 |
Why?
| Ultracentrifugation | 8 | 2018 | 48 | 1.080 |
Why?
| Protein Binding | 13 | 2015 | 2121 | 0.850 |
Why?
| Sodium Chloride | 5 | 2023 | 138 | 0.810 |
Why?
| Education, Pharmacy | 1 | 2024 | 119 | 0.800 |
Why?
| Protons | 1 | 2023 | 80 | 0.790 |
Why?
| Binding Sites | 15 | 2018 | 1252 | 0.770 |
Why?
| Gene Expression Regulation | 8 | 2015 | 2548 | 0.770 |
Why?
| Estrogen Receptor alpha | 2 | 2014 | 133 | 0.760 |
Why?
| Protein Multimerization | 6 | 2021 | 179 | 0.680 |
Why?
| Transcription, Genetic | 7 | 2014 | 1418 | 0.670 |
Why?
| Curriculum | 1 | 2024 | 917 | 0.570 |
Why?
| Dynamic Light Scattering | 3 | 2023 | 7 | 0.540 |
Why?
| Dimerization | 7 | 2012 | 192 | 0.480 |
Why?
| Drug Industry | 1 | 2016 | 106 | 0.480 |
Why?
| Receptors, Estrogen | 4 | 2015 | 426 | 0.470 |
Why?
| Research Personnel | 1 | 2016 | 156 | 0.470 |
Why?
| Teaching | 1 | 2016 | 214 | 0.450 |
Why?
| Immunoglobulin G | 1 | 2018 | 847 | 0.430 |
Why?
| Mammary Tumor Virus, Mouse | 2 | 2015 | 44 | 0.410 |
Why?
| Proteins | 2 | 2012 | 942 | 0.390 |
Why?
| Receptors, Androgen | 1 | 2013 | 147 | 0.390 |
Why?
| Protein Isoforms | 7 | 2012 | 391 | 0.380 |
Why?
| Protein Structure, Tertiary | 5 | 2016 | 840 | 0.350 |
Why?
| Biomedical Research | 1 | 2016 | 638 | 0.340 |
Why?
| Potassium | 1 | 2010 | 143 | 0.320 |
Why?
| DNA-Binding Proteins | 7 | 2014 | 1443 | 0.320 |
Why?
| Kinetics | 5 | 2015 | 1642 | 0.320 |
Why?
| Sodium | 1 | 2010 | 206 | 0.310 |
Why?
| Models, Molecular | 4 | 2018 | 1492 | 0.300 |
Why?
| Protein Footprinting | 1 | 2008 | 11 | 0.290 |
Why?
| DNA Footprinting | 3 | 2015 | 33 | 0.290 |
Why?
| Deoxyribonucleases | 1 | 2008 | 23 | 0.290 |
Why?
| Receptors, Cytoplasmic and Nuclear | 2 | 2007 | 217 | 0.260 |
Why?
| Models, Biological | 3 | 2008 | 1722 | 0.260 |
Why?
| Recombinant Proteins | 4 | 2016 | 1304 | 0.250 |
Why?
| Transcription Factors | 3 | 2012 | 1651 | 0.250 |
Why?
| Trans-Activators | 1 | 2007 | 388 | 0.230 |
Why?
| Molecular Sequence Data | 6 | 2012 | 2832 | 0.230 |
Why?
| Transcriptional Activation | 3 | 2012 | 366 | 0.230 |
Why?
| Humans | 30 | 2024 | 129650 | 0.230 |
Why?
| Faculty, Pharmacy | 1 | 2024 | 20 | 0.220 |
Why?
| Protein Conformation | 5 | 2009 | 859 | 0.220 |
Why?
| Schools, Pharmacy | 1 | 2024 | 46 | 0.220 |
Why?
| Long Interspersed Nucleotide Elements | 1 | 2003 | 30 | 0.210 |
Why?
| Students, Pharmacy | 1 | 2024 | 96 | 0.210 |
Why?
| Cytokines | 1 | 2011 | 2017 | 0.200 |
Why?
| Base Sequence | 4 | 2012 | 2142 | 0.200 |
Why?
| Xanthine Dehydrogenase | 1 | 2002 | 25 | 0.190 |
Why?
| Xanthine Oxidase | 1 | 2002 | 78 | 0.190 |
Why?
| Oxidoreductases | 1 | 2002 | 92 | 0.190 |
Why?
| Allosteric Regulation | 3 | 2010 | 99 | 0.180 |
Why?
| Static Electricity | 1 | 2021 | 116 | 0.180 |
Why?
| Chemistry, Pharmaceutical | 1 | 2021 | 107 | 0.170 |
Why?
| Viral Proteins | 2 | 2001 | 328 | 0.170 |
Why?
| Biophysical Phenomena | 2 | 2015 | 64 | 0.170 |
Why?
| Repressor Proteins | 5 | 2000 | 406 | 0.160 |
Why?
| In Vitro Techniques | 2 | 2015 | 1085 | 0.150 |
Why?
| Chromatography, Gel | 2 | 2017 | 127 | 0.140 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1998 | 330 | 0.140 |
Why?
| Protein Aggregates | 1 | 2017 | 67 | 0.130 |
Why?
| Animals | 12 | 2018 | 35361 | 0.130 |
Why?
| Public-Private Sector Partnerships | 1 | 2016 | 42 | 0.130 |
Why?
| Immunoglobulins, Intravenous | 1 | 2017 | 130 | 0.130 |
Why?
| Luciferases | 2 | 2012 | 148 | 0.120 |
Why?
| Structure-Activity Relationship | 2 | 2007 | 548 | 0.120 |
Why?
| Transfection | 3 | 2012 | 911 | 0.110 |
Why?
| NF-kappa B | 1 | 2018 | 653 | 0.110 |
Why?
| Recombinant Fusion Proteins | 2 | 2015 | 643 | 0.110 |
Why?
| Mutation, Missense | 1 | 2015 | 317 | 0.100 |
Why?
| Hydrolysis | 2 | 2005 | 186 | 0.100 |
Why?
| Molecular Weight | 2 | 2005 | 332 | 0.100 |
Why?
| Cells, Cultured | 2 | 2012 | 4083 | 0.100 |
Why?
| Sodium-Potassium-Exchanging ATPase | 1 | 2012 | 51 | 0.090 |
Why?
| Progestins | 1 | 2012 | 78 | 0.090 |
Why?
| Evolution, Molecular | 1 | 2015 | 466 | 0.090 |
Why?
| Hydrodynamics | 1 | 2011 | 40 | 0.090 |
Why?
| Hydrogen-Ion Concentration | 2 | 2007 | 544 | 0.090 |
Why?
| Algorithms | 1 | 2018 | 1622 | 0.090 |
Why?
| Tamoxifen | 2 | 2000 | 200 | 0.080 |
Why?
| Biological Phenomena | 1 | 2009 | 4 | 0.080 |
Why?
| Breast Neoplasms | 3 | 2012 | 2142 | 0.080 |
Why?
| Tandem Repeat Sequences | 1 | 2008 | 18 | 0.070 |
Why?
| Spodoptera | 1 | 2008 | 37 | 0.070 |
Why?
| Binding, Competitive | 1 | 2008 | 206 | 0.070 |
Why?
| DNA Fingerprinting | 1 | 2007 | 25 | 0.070 |
Why?
| Substrate Specificity | 1 | 2008 | 368 | 0.070 |
Why?
| Allosteric Site | 1 | 2006 | 19 | 0.060 |
Why?
| Energy Metabolism | 1 | 2012 | 874 | 0.060 |
Why?
| Salts | 1 | 2005 | 37 | 0.060 |
Why?
| MicroRNAs | 1 | 2012 | 678 | 0.060 |
Why?
| Solutions | 1 | 2005 | 151 | 0.060 |
Why?
| Spectrometry, Fluorescence | 1 | 2005 | 171 | 0.060 |
Why?
| Peptide Hydrolases | 1 | 2005 | 107 | 0.060 |
Why?
| Protein Structure, Quaternary | 1 | 2003 | 122 | 0.050 |
Why?
| Ligands | 1 | 2005 | 622 | 0.050 |
Why?
| Models, Genetic | 1 | 2006 | 594 | 0.050 |
Why?
| Microscopy, Atomic Force | 1 | 2003 | 116 | 0.050 |
Why?
| HeLa Cells | 3 | 2018 | 608 | 0.050 |
Why?
| Models, Statistical | 1 | 2007 | 623 | 0.050 |
Why?
| Protein Processing, Post-Translational | 1 | 2005 | 455 | 0.050 |
Why?
| Chromatography | 1 | 2002 | 25 | 0.050 |
Why?
| Chymotrypsin | 1 | 2002 | 19 | 0.050 |
Why?
| Molecular Chaperones | 1 | 2003 | 182 | 0.050 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 1 | 2002 | 110 | 0.050 |
Why?
| Trypsin | 1 | 2002 | 74 | 0.050 |
Why?
| Phenylalanine | 1 | 2002 | 65 | 0.050 |
Why?
| Disulfides | 1 | 2002 | 97 | 0.050 |
Why?
| Methionine | 1 | 2002 | 158 | 0.050 |
Why?
| Mifepristone | 2 | 2000 | 63 | 0.050 |
Why?
| Cross-Linking Reagents | 1 | 2002 | 205 | 0.050 |
Why?
| Estrogen Receptor Modulators | 1 | 2000 | 17 | 0.040 |
Why?
| Protein Denaturation | 1 | 2001 | 75 | 0.040 |
Why?
| Spectrophotometry, Ultraviolet | 1 | 2001 | 84 | 0.040 |
Why?
| Circular Dichroism | 1 | 2001 | 148 | 0.040 |
Why?
| Cysteine | 1 | 2002 | 195 | 0.040 |
Why?
| Biophysics | 1 | 2001 | 68 | 0.040 |
Why?
| Microscopy, Fluorescence | 1 | 2002 | 400 | 0.040 |
Why?
| Virus Assembly | 1 | 2001 | 76 | 0.040 |
Why?
| Sulfhydryl Compounds | 1 | 2002 | 187 | 0.040 |
Why?
| DNA Primers | 1 | 2001 | 510 | 0.040 |
Why?
| Endopeptidases | 1 | 2000 | 87 | 0.040 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2002 | 582 | 0.040 |
Why?
| Lysine | 1 | 2002 | 286 | 0.040 |
Why?
| Cattle | 1 | 2002 | 976 | 0.040 |
Why?
| Protein Folding | 1 | 2000 | 266 | 0.040 |
Why?
| Hot Temperature | 1 | 2001 | 370 | 0.040 |
Why?
| Oxygen | 1 | 2002 | 915 | 0.030 |
Why?
| Mutagenesis, Site-Directed | 1 | 2018 | 361 | 0.030 |
Why?
| Amino Acid Substitution | 1 | 2018 | 282 | 0.030 |
Why?
| Cold Temperature | 1 | 1998 | 155 | 0.030 |
Why?
| Ribosomal Proteins | 1 | 1997 | 77 | 0.030 |
Why?
| Protein Stability | 1 | 2017 | 162 | 0.030 |
Why?
| Crystallography, X-Ray | 1 | 2018 | 436 | 0.030 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2018 | 257 | 0.030 |
Why?
| Nuclear Proteins | 2 | 2000 | 663 | 0.030 |
Why?
| Drug Resistance, Neoplasm | 1 | 2000 | 759 | 0.030 |
Why?
| HEK293 Cells | 1 | 2018 | 697 | 0.030 |
Why?
| Centrifugation, Density Gradient | 1 | 1994 | 39 | 0.030 |
Why?
| Viral Regulatory and Accessory Proteins | 1 | 1994 | 27 | 0.030 |
Why?
| Potassium Chloride | 1 | 1994 | 40 | 0.030 |
Why?
| Calibration | 1 | 2015 | 140 | 0.030 |
Why?
| Bacteriophage lambda | 1 | 1994 | 88 | 0.030 |
Why?
| Models, Chemical | 1 | 1994 | 265 | 0.030 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2018 | 1198 | 0.030 |
Why?
| Operator Regions, Genetic | 1 | 1992 | 7 | 0.020 |
Why?
| Deoxyribonucleases, Type II Site-Specific | 1 | 1992 | 15 | 0.020 |
Why?
| Microarray Analysis | 1 | 2012 | 122 | 0.020 |
Why?
| Time Factors | 1 | 2002 | 6556 | 0.020 |
Why?
| 3' Untranslated Regions | 1 | 2012 | 138 | 0.020 |
Why?
| Genes, Reporter | 1 | 2012 | 267 | 0.020 |
Why?
| COS Cells | 2 | 2003 | 185 | 0.020 |
Why?
| Data Interpretation, Statistical | 1 | 1992 | 335 | 0.020 |
Why?
| Protein Biosynthesis | 1 | 2012 | 406 | 0.020 |
Why?
| Nuclear Receptor Co-Repressor 2 | 2 | 2000 | 15 | 0.020 |
Why?
| Nuclear Receptor Co-Repressor 1 | 2 | 2000 | 16 | 0.020 |
Why?
| Mice | 2 | 2003 | 16937 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2015 | 3083 | 0.020 |
Why?
| Cell Movement | 1 | 2012 | 945 | 0.020 |
Why?
| Male | 1 | 2013 | 63681 | 0.020 |
Why?
| Cell Line, Tumor | 1 | 2012 | 3215 | 0.010 |
Why?
| Signal Transduction | 1 | 1996 | 4925 | 0.010 |
Why?
| Sequence Alignment | 1 | 2003 | 332 | 0.010 |
Why?
| Sequence Homology, Amino Acid | 1 | 2003 | 372 | 0.010 |
Why?
| Mutagenesis | 1 | 2003 | 181 | 0.010 |
Why?
| Nuclear Receptor Coactivator 1 | 1 | 2000 | 11 | 0.010 |
Why?
| Drug Resistance | 1 | 2000 | 166 | 0.010 |
Why?
| Histone Acetyltransferases | 1 | 2000 | 64 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 2003 | 2058 | 0.010 |
Why?
| Peptide Fragments | 1 | 2003 | 692 | 0.010 |
Why?
| Cell Division | 1 | 2000 | 797 | 0.010 |
Why?
| Leucine Zippers | 1 | 1997 | 17 | 0.010 |
Why?
| Yeasts | 1 | 1997 | 52 | 0.010 |
Why?
| DNA, Complementary | 1 | 1997 | 270 | 0.010 |
Why?
| Female | 3 | 2012 | 68776 | 0.010 |
Why?
| DNA, Superhelical | 1 | 1992 | 11 | 0.010 |
Why?
| Electrophoresis | 1 | 1992 | 30 | 0.010 |
Why?
| Least-Squares Analysis | 1 | 1992 | 78 | 0.010 |
Why?
| Plasmids | 1 | 1992 | 358 | 0.010 |
Why?
|
|
Bain's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|